Skip to content
55

stye eye drops

Worth a look

Shows low returns (0.1%), but soft demand (+2.3% this quarter) keeps it on the watch list.

Market size 52Growth 28Conversion 82Competition 38Returns 99Price range 62Avg price 72Brand share 42Review moat 30Quality gap 70

Returns

Incredible0.1%

return rate — above 6% kills the launch gate

Conversion

Great8.8%

search→purchase rate — share of searches ending in a sale

Avg price

Good$14.69

avg listing price — sweet spot $15–$100

Quality gap

Good4.3★

avg incumbent rating — lower means beatable quality

Price range

Good$5.38–$30.93

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Good$311K

$311K/yr · 240K searches

Brand share

Okay80%

top-5 brand share — brands hold most of the demand

Competition

Okay62%

top-5 click share — leaders hold, buyers still browse

Review moat

Okay3,514.05

avg incumbent reviews — the moat a new listing must climb

Growth

Okay+2.3%

90-day search growth — must beat 0% to launch

Competition

The top 5 products take 62% of clicks — established leaders, but buyers still shop beyond them.

Brands

15 rising

Sellers

102

Top-5 brand share

80%

Open market

17%

  • Stye53%
  • brazmedics9%
  • Systane8%
  • NOVEHA5%
  • Generic5%
  • Tiepetly3%
  • Open — no brand owns it (9 brands, 17%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%$31K20%$62K30%$93K40%$124K1101001K10K100K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)1 product missing review or click data not plotted

All 21 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — +2.3% search growth over the last 90 days.
5K3KSpike '24Spike '25SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.4×